Drug intelligence / Profile preview

bone marrow mesenchymal stromal cells-derived extracellular vesicles

Development stage
Phase 2
Lead developer
EV Biologics
Modality
Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Local Injection (e.g., Intra-articular)
01

Overview

Bone marrow mesenchymal stromal cells-derived extracellular vesicles (BM-MSC-EVs) are nanoscale lipid bilayer-enclosed particles released by bone marrow mesenchymal stromal (or stem) cells. These vesicles include exosomes and microvesicles and act as mediators of intercellular communication by transferring proteins, mRNA, non-coding RNAs, and lipids to recipient cells. BM-MSC-EVs exert similar biological effects as their parental MSCs through mechanisms such as receptor-ligand interactions, direct membrane fusion, or endocytosis/phagocytosis. They have shown therapeutic efficacy in various preclinical models for a range of diseases due to their ability to modulate immune responses, promote tissue repair/regeneration, and deliver bioactive molecules. Their use is being explored both as substitutes for intact cell therapies and as vehicles for targeted drug delivery[1][2].

Other names
bone marrow MSC-derived EVsbone marrow mesenchymal stem cell-derived extracellular vesiclesBM-MSC-EVs

Beyond the preview

Go deeper on bone marrow mesenchymal stromal cells-derived extracellular vesicles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bone marrow mesenchymal stromal cells-derived extracellular vesicles.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call